Published in TB and Outbreaks Week, September 4th, 2001
The findings of M.C. Remington and colleagues, published in Infection and Immunity may have implications for vaccine development.
"We investigated the borreliacidal antibody response in sera and the amount of antibody produced by cultured lymph node cells of C3H/HeJ mice vaccinated with outer surface protein C (OspC)," reported Remington and coworkers. They noted that potent borreliacidal activity...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week